8-K
filed June 4, 2026, 8:00 AM ET
ticker IMNN
CIK 0000749647
debt
confidence high
sentiment neutral
materiality 0.70
Imunon, Inc. (IMNN): debt financing — IMUNON secures up to $10M through preferred stock and secured notes for Phase 3 trial
Imunon, Inc.
- Gross proceeds of $10M from 250 Series A Preferred shares ($2.5M) and secured promissory notes ($7.72M total).
- Notes mature in 18 months; A-1 Note at 8% interest, B Note at 5%; secured by assets except IP.
- $5M placed in cash collateral; remaining $5M for general corporate purposes including Phase 3 OVATION 3 trial.
- Preferred stock is non-convertible, non-voting, 8% annual return; redeemable at 110% of liquidation amount.
- Financing structured as non-dilutive with no warrants; management highlights shareholder-friendly terms.
Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Imunon, Inc. incurred debt of $5,000,000 with Streeterville Capital, LLC at 5% per annum maturing 18 months following the Closing Date.
- Principal
- $5,000,000
- Counterparty
- Streeterville Capital, LLC
- Rate
- 5% per annum
- Maturity
- 18 months following the Closing Date
- Event
- incurrence
Exact text from the filing
(ii) a Secured Promissory Note A-1 in an original principal amount of $2,720,000 (the “ A-1 Note ”); and (iii) a Secured Promissory Note B in an original principal amount of $5,000,000 (the “ B Note ” and together with the A-1 Note, the “ Notes ”). The transactions contemplated by the Securities Purchase Agreement (collectively, the “ Transaction ”) closed on
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Imunon, Inc. incurred debt of $2,720,000 with Streeterville Capital, LLC at 8% per annum maturing 18 months following the Closing Date.
- Principal
- $2,720,000
- Counterparty
- Streeterville Capital, LLC
- Rate
- 8% per annum
- Maturity
- 18 months following the Closing Date
- Event
- incurrence
Exact text from the filing
(the “ Series A Preferred Stock ”), at a price of $10,000 per share, for aggregate proceeds of $2,500,000; (ii) a Secured Promissory Note A-1 in an original principal amount of $2,720,000 (the “ A-1 Note ”); and (iii) a Secured Promissory Note B in an original principal amount of $5,000,000 (the “ B Note ” and together with the A-1 Note, the “ Notes ”). The
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Imunon, Inc.: Filed a Certificate of Designation for Series A Preferred Stock designating 400 shares (effective 2026-06-01).
- Change
- charter amendment
- Effective
- 2026-06-01
Exact text from the filing
On June 1, 2026, the Company filed a certificate of designation of preferences and rights (the “ Certificate of Designation ”) of the Series A Preferred Stock with the Secretary of State of the State of Delaware, designating 400 shares of Series A Preferred Stock, which became effective upon filing.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.99
Imunon, Inc. entered into Securities Purchase Agreement with Streeterville Capital, LLC valued at Total financing of $10,000,000; issuance of 250 shares of Series A Preferred Stock at $10,000 per sh (effective 2026-06-02).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Streeterville Capital, LLC
- Value
- Total financing of $10,000,000; issuance of 250 shares of Series A Preferred Stock at $10,000 per sh
- Effective
- 2026-06-02
Exact text from the filing
On June 2, 2026, Imunon, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with Streeterville Capital, LLC (the “ Investor ”), providing for the issuance and sale by the Company, and the purchase by the Investor, of (i) 250 shares (the “ Preferred Shares ”) of the Company’s Series A Preferred Stock, par value $0.01 per share (the “ Series A Preferred Stock ”), at a price of $10,000 per share, for aggregate proceeds of $2,500,000; (ii) a Secured Promissory Note A-1 in an original principal amount of $2,720,000 (the “ A-1 Note ”); and (iii) a Secured Promissory Note B in an original principal amount of $5,000,000 (the “ B Note ” and together with the A-1 Note, the “ Notes ”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.